Tackling some of the most difficult topics surrounding medical devices and approval with the FDA, Bill Link, Managing Director for Versant Ventures leads Malvina Eydelman, Director for the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, through an interview that brings her highly diverse and expert knowledge to the forefront for attendees of the 2nd Annual Ophthalmology Innovation Summit.
William J. Link, PhD
Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986.
Malvina B. Eydelman, MD
Dr. Eydelman joined FDA in 1995 and for the last 17 years, has served as the Director of FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices (DOED), and subsequently Director of the FDA’s Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices (DONED).